NIH Grants & Funding /
Clinical Trial: Optional
| FOA Number | Co-Funders | Title | Clinical Trial | Activity Code | Application Due Date |
|---|---|---|---|---|---|
| RFA-CA-23-033 | National Cancer Institute (NCI) | Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional) | Optional | U01 | ClosedDecember 16, 2023 |
| RFA-CA-24-005 | National Cancer Institute (NCI) | Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) | Optional | U01 | ClosedOctober 13, 2023 |
| PAR-21-190 | National Cancer Institute (NCI) | Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) | Optional | R01 | ClosedNovember 05, 2023 | March 07, 2024 |
| RFA-DK-21-004 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | The Autoantigens and Neoantigens Function in the Etiology and Pathophysiology of Type 1 Diabetes | Optional | R01 | Closed22 June 2021 and 9 March 2022 |
| PAR-21-329 | National Cancer Institute (NCI) | Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) | Optional | R01 | ClosedJune 05, 2023 | October 05, 2023 | February 05, 2024 | June 05, 2024 | October 05, 2024 |
| PAR-22-109 | National Cancer Institute (NCI) | Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) | Optional | R21 | ClosedJune 16, 2023 | October 16, 2023 | February 16, 2024 | June 16, 2024 | October 16, 2024 | February 16, 2025 |
| PAR-22-105 | National Cancer Institute (NCI) | Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) | Optional | R01 | ClosedJune 05, 2023 | October 05, 2023 | February 05, 2024 | June 05, 2024 | October 05, 2024 | February 05, 2025 |
| NOT-CA-23-059 | National Cancer Institute (NCI) | Notice of Special Interest (NOSI): Administrative Supplements for the Dog Oncology Grant Supplement (DOGS) Program | Optional | P01, P50, R01, R37, U01, U19, U24, U54 | ClosedJune 16, 2023 |
| PAR-22-216 | National Cancer Institute (NCI) | NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) | Optional | R21 | ClosedJune 12, 2023 | October 10, 2023 | February 13, 2024 | June 12, 2024 | October 10, 2024 | February 13, 2025 | June 12, 2025 |
| PAR-22-243 | National Cancer Institute (NCI) | Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) | Optional | R01 | ClosedJune 05, 2023; October 05, 2023; February 05, 2024; June 05, 2024; October 05, 2024; February 05, 2025; June 05, 2025 |
| RFA-MH-22-136 | National Institute of Mental Health (NIMH), National Institute on Aging (NIA) | Social disconnection and Suicide Risk in Late Life | Optional | R21 | ClosedMarch 15, 2022 and October 15, 2022 |
| PA-21-199 | National Institute of Mental Health (NIMH) | Research on Autism Spectrum Disorders | Optional | R03 | ClosedOctober 16, 2021 to February 16, 2024 |
| PA-21-200 | National Institute of Mental Health (NIMH) | Research on Autism Spectrum Disorders | Optional | R21 | ClosedOctober 16, 2021 to February 16, 2024 |
| PA-21-201 | National Institute of Mental Health (NIMH) | Research on Autism Spectrum Disorders | Optional | R01 | Closed5 October 2021 to 5 February 2024 |